Arterium Corporation sponsors arterial hypertension problematics conference

On May 27–29, the annual applied research conference on medico-social problematics of arterial hypertension in Ukraine was held in Lviv. This year, over 300 Ukrainian cardiologists and physicians visited the event. Funded by Arterium Corporation, the conference was organised by M.D. Strazhesko Institute of Cardiology, AMNU and the Ministry of Health of Ukraine.
At the conference, prominent experts in the mentioned domain reported on Arterium Corporation's products. In his report on the application of aldosterone antagonists in the treatment of post-infarction cardiac impairment, Prof. Dr. scient. med. Oleg J. Zharinov told about Renial, a new medicinal product from Arterium Corporation indicated for the treatment of patients with clinical evidence of cardiac impairment following a myocardial infarction.
The second speaker—Prof. Dr. scient. med. Yuriy M. Sirenko—told about Kasark in his report on Candesartan application in the treatment of patients with arterial hypertension.
At Arterium Corporation's stand, conference participants could get all necessary information about advantages of Renial, Kasark, Corvasan, and Thiotriazolin, and their application.